| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer
1 company
Darius Kharabi last filed a Form 4 in October 2025, as Chief Business Officer at KALA. Darius Kharabi's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Darius Kharabi's trades have earned a middling insider score of 66/100 across 7 rated trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of +39.8%.
At the last filing, the largest reported position was 41,760 shares of KALA. The KALA filings lean toward selling, a net 34,842 shares.
Darius Kharabi has 12 Form 4 filings on record from November 2021 to October 2025, all as Chief Business Officer at Kala Bio (KALA), 2021–2025.
The 22 reported transactions were 7 open-market sales, 7 stock awards, 5 option or other derivative awards and 2 dispositions back to the company, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 7 sales worth about $89K.
The largest open-market sale was 5,158 shares of KALA at an average $4.75 on June 26, 2024, about $25K. Twelve months later KALA was up 14%.
None of the 7 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from October 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | KALA Kala Bio, Inc. | Chief Business Officer | Sell | 20,806 | $0.83 | $17,268.98 | -33.3% | -26.7% | -99.5% | |
| Jun 24, 2025 | KALA Kala Bio, Inc. | Chief Business Officer | Sell | 4,511 | $4.01 | $18,089.11 | -6.7% | +363.8% | -25.0% | |
| Jun 3, 2025 | KALA Kala Bio, Inc. | Chief Business Officer | Sell | 730 | $3.74 | $2,730.20 | -1.1% | +198.0% | -45.5% | |
| Jan 6, 2025 | KALA Kala Bio, Inc. | Chief Business Officer | Sell | 2,021 | $7.63 | $15,420.23 | -2.9% | -50.3% | -91.3% | |
| Jun 26, 2024 | KALA Kala Bio, Inc. | Chief Business Officer | Sell | 5,158 | $4.75 | $24,500.50 | -7.9% | +20.0% | +14.2% | |
| May 31, 2024 | KALA Kala Bio, Inc. | Chief Business Officer | Sell | 231 | $6.09 | $1,406.79 | -0.4% | -12.4% | -44.6% | |
| Jan 4, 2024 | KALA Kala Bio, Inc. | Chief Business Officer | Sell | 1,385 | $6.73 | $9,321.05 | -2.1% | +11.1% | +13.3% |